Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primaquine Double Dose for P. vivax in Colombia
NCT05232227Phase 3Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Jan 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of primaquine in Plasmodium vivax malaria, sponsored by University of California, San Francisco. Planned start Jan 2023; status: withdrawn.
02
Drugs
primaquine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT05232227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05232227.